Literature DB >> 10903973

Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.

M Weiss1, O Kuhlmann, D Y Hung, M S Roberts.   

Abstract

1. The binding kinetics of diclofenac to hepatocellular structures were evaluated in the perfused rat liver using the multiple indicator dilution technique and a stochastic model of organ transit time density. 2. The single-pass, in situ rat liver preparation was perfused with buffer solution (containing 2% albumin) at 30 ml min(-1). Diclofenac and [(14)C]-sucrose (extracellular reference) were injected simultaneously as a bolus dose into the portal vein (six experiments in three rats). An analogous series of experiments was performed with [(14)C]-diclofenac and [(3)H]-sucrose. 3. The diclofenac outflow data were analysed using three models of intracellular distribution kinetics, assuming (1) instantaneous distribution and binding (well-mixed model), (2) 'slow' binding at specific intracellular sites after instantaneous distribution throughout the cytosol (slow binding model), and (3) 'slowing' of cytoplasmic diffusion due to instantaneous binding (slow diffusion model). 4. The slow binding model provided the best description of the data. The rate constants for cellular influx and sequestration were 0.126+/-0. 026 and 0.013+/-0.009 s(-1), respectively. The estimated ratio of cellular initial distribution volume to extracellular volume of 2.82 indicates an almost instantaneous distribution in the cellular water space, while the corresponding ratio of 5.54 estimated for the apparent tissue distribution volume suggests a relatively high hepatocellular binding. The non-instantaneous intracellular equilibration process was characterized by time constants of the binding and unbinding process of 53.8 and 49.5 s, respectively. The single-pass availability of diclofenac was 86%. The results obtained with [(14)C]-diclofenac and [(3)H]-sucrose were not statistically different.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903973      PMCID: PMC1572206          DOI: 10.1038/sj.bjp.0703448

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Pharmacokinetic curve fitting using numerical inverse Laplace transformation.

Authors:  M Schalla; M Weiss
Journal:  Eur J Pharm Sci       Date:  1999-03       Impact factor: 4.384

3.  Transfer of enalaprilat across rat liver cell membranes is barrier limited.

Authors:  A J Schwab; F Barker; C A Goresky; K S Pang
Journal:  Am J Physiol       Date:  1990-03

Review 4.  Hepatic clearance models: comparison of the dispersion and Goresky models in outflow profiles from multiple indicator dilution rat liver studies.

Authors:  R G Tirona; A J Schwab; W Geng; K S Pang
Journal:  Drug Metab Dispos       Date:  1998-05       Impact factor: 3.922

5.  On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed.

Authors:  M Weiss; C Stedtler; M S Roberts
Journal:  Bull Math Biol       Date:  1997-09       Impact factor: 1.758

6.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

7.  Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

Authors:  M S Roberts; J D Donaldson; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

Review 8.  The isolated perfused rat liver: preparation and application.

Authors:  A W Wolkoff; K L Johansen; T Goeser
Journal:  Anal Biochem       Date:  1987-11-15       Impact factor: 3.365

9.  Sex differences in multiple steps in hepatic transport of palmitate support a balanced uptake mechanism.

Authors:  B A Luxon; D C Holly; M T Milliano; R A Weisiger
Journal:  Am J Physiol       Date:  1998-01

10.  Kinetic analysis of vascular marker distribution in perfused rat livers after regeneration following partial hepatectomy.

Authors:  M Weiss; L N Ballinger; M S Roberts
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

View more
  7 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

3.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

4.  Characterization of the physiological spaces and distribution of tolbutamide in the perfused rat pancreas.

Authors:  Kent John Fanning; Michael S Roberts
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.

Authors:  Daniel Y Hung; Gerhard A Siebert; Ping Chang; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  Fractal structure of the liver: effect on drug elimination.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-05       Impact factor: 2.745

7.  Effects of dose, flow rate, and bile acid on diclofenac disposition in the perfused rat liver.

Authors:  Misato Uraki; Atsushi Kawase; Yuka Matsushima; Masahiro Iwaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-06       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.